Location History:
- Tokyo, JP (2003 - 2006)
- Itabashi-ku, JP (2006)
Company Filing History:
2 out of 417 
1 out of 329 
1 out of 1,716 
Years Active: 2003-2006
Title: Kazuma Kamigiri: Innovator in Pharmaceutical Compounds
Introduction
Kazuma Kamigiri is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that target human cancer cells and multidrug-resistant bacteria. His innovative work has led to the filing of several patents, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Kazuma Kamigiri holds 3 patents that reflect his commitment to addressing critical health challenges. One of his latest inventions is a depsipeptide compound, which exhibits cytotoxic activity and TGF-β-like activity against human cancer cells. This compound is particularly valuable as an antitumor agent and is included in a pharmaceutical composition. Another significant patent involves thiopeptide compounds, which are derived from a microorganism belonging to a specific genus. The compounds QN3323 and thiocillin I/II, collected from the culture medium, are promising candidates for treating infections caused by multidrug-resistant bacteria.
Career Highlights
Throughout his career, Kazuma Kamigiri has worked with prominent companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research and development projects. His work in these organizations has further solidified his reputation as an innovator in the field.
Collaborations
Kazuma has collaborated with several talented individuals in his field, including Koji Nagai and Nakako Arao. These partnerships have allowed him to enhance his research and develop groundbreaking solutions in pharmaceuticals.
Conclusion
Kazuma Kamigiri's contributions to pharmaceutical innovations are noteworthy, particularly in the development of compounds that address significant health issues. His patents and collaborations reflect his commitment to improving medical treatments and combating drug resistance. His work continues to inspire future advancements in the field.